ZYMO
Board
3 directors, no change since 2025Manager
appointed by deed of 27-04-2017
term without a fixed end
listed in the 2026 annual accounts, filed on 28-09-2026
Director
appointed by deed of 31-01-2023
term without a fixed end
listed in the 2026 annual accounts, filed on 28-09-2026
Director
appointed by deed of 16-01-2025
term for the life of the company
listed in the 2026 annual accounts, filed on 28-09-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “het bestuursorgaan Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder. De…”deed of 31-01-2023
Mandates through the years
3 names, the dashed line is todayManager
Director
Director
Boardmandate already running before its first mention
Mandates as a list
-
- Manager, appointed by deed of 27-04-2017, still in office
-
- Director, since before 31-03-2022
-
- Director, appointed by deed of 16-01-2025, still in office
Control
Founder
This company
ZYMO
Equity €166,482
Profit €47,043 in 2026
Capital
- Capital
- €25,000
- Shares
- 100
- Contribution per share
- €250
- Equity per share
- €1,665 in 2026
- Source
- deed of 27-04-2017
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 27-04-2017 (in Dutch)
- Profit allocationThe articles set how profit is distributed. A BV may only pay out after a balance-sheet and liquidity test.
- Na wettelijk verplichte voorafname voor samenstelling reservefonds, overschot ter beschikking van vergadering die op voorstel van zaakvoerder bestemming bepaaltdeed of 27-04-2017 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of September at 19:00deed of 31-01-2023 (in Dutch)
Shareholders
At incorporation
deed of 27-04-2017 ↗
- 100 shares (100%)